Cotellic Tablet, Film Coated
Product Images NDC 50242-717

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Cotellic (NDC 50242-717). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Genentech, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Cotellic 01)

Chemical structure of cobimetinib, the active ingredient in Cotellic 20 mg film-coated tablets by Genentech, Inc. The diagram shows the molecular arrangement including aromatic rings, fluorine substitution, and a carboxylic acid moiety represented separately.*

FDA Label Image

Figure 1 (Cotellic 02)

A survival distribution function Kaplan-Meier curve comparing Vemurafenib plus Cobimetinib versus Vemurafenib plus Placebo over 30 months. The graph shows patient survival percentages varying over time, with censored data points marked. Patient numbers at risk decline over time for both treatment groups as listed below the graph.*

FDA Label Image

Principal Display Panel (63 Tablet Bottle Label)

Label of Cotellic (cobimetinib) tablets showing 20 mg strength. The label indicates the product is prescription only and comes in a package of 63 tablets. The labeler is Genentech, Inc. The NDC number 50242-717-01 is visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.